FDA Orders Review of Painkiller Data, Issues Cox-2 Advisory
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
55610
The Food and Drug Administration recommended Thursday that doctors limit prescriptions for the popular pain pills Celebrex and Bextra because recent
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
210819
The Food and Drug Administration issued a public health advisory Thursday, recommending doctors limit the use of Pfizer Inc.&#39;s Celebrex and Bextra to patients who can&#39;t take other pain medicines.
484756
Responding to public criticism of its handling of the controversial arthritis drug Vioxx, the US Food and Drug Administration on Wednesday defended its oversight of the monitoring process and said it acted in the best interests of the public&#39;s safety.
306400
Less than a week after two sets of new data raised questions about the cardiovascular safety of two widely used painkillers, the Pfizer Inc.
466531
New evidence shows all popular arthritis painkillers known as COX-2 inhibitors may put users at greater risk of heart attacks and strokes, the latest addition to the recent crop of safety concerns for the drugs.
367072
U.S. drug regulators on Wednesday will issue a public health advisory about the potential risks of a pain drug made by Cephalon Inc, an agency official said.
905
Two leading heart experts called for  urgent investigations on Wednesday into whether all painkilling  drugs known as COX-2 inhibitors may raise the risk of heart  attack in some people.
3564
A day after troubling reports about the popular pain relief drug Celebrex, more questions are being asked about the approval process for such drugs.
91514
A veteran U.S. Food and Drug  Administration scientist will unveil new data on Thursday  before an expert panel charged with determining whether pain  relievers similar to Merck & Co. Inc.'s now-withdrawn Vioxx  should remain on the market.
232811
The US Food and Drug Administration today announced a five-step program to bolster drug safety evaluations. The news comes after controversy over the recall of the arthritis drug Vioxx and risks to children on antidepressants.
492351
The U.S. Food and Drug  Administration on Monday issued a warning to patients taking  the painkiller naproxen after a government study showed the  over-the-counter medicine can cause an increased risk of heart  problems.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
467561
Dec. 23, 2004 - The Food and Drug Administration today issued a Public Health Advisory summarizing the agency&#39;s recent cautions and recommendations concerning the use of non-steroidal anti-inflammatory drug
167646
The US Food and Drug Administration Thursday said people should limit their use of non-steroidal anti-inflammatory drug products. The FDA issued a Public Health Advisory about the use of NSAIDs, including
326837
Last weekâs dramatic withdrawal of the COX-2 inhibitor rofecoxib (Vioxx) is discussed in this weekâs lead editorial in THE LANCET, which comments that more vigilant drug licensing is vital to prevent the endangering of patientsâ health.